Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis

IMPORTANCE: Debate continues about the value of event adjudication in clinical trials and whether independent centralized assessments improve reliability and validity of study results in masked randomized trials compared with local, investigator-assessed end points. OBJECTIVE: To assess the results...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Netw Open
Autores principales: Farrant, Mary, Easton, J. Donald, Adelman, Eric E., Cucchiara, Brett L., Barsan, William G., Tillman, Holly J., Elm, Jordan J., Kim, Anthony S., Lindblad, Anne S., Palesch, Yuko Y., Zhao, Wenle, Pauls, Keith, Walsh, Kyle B., Martí-Fàbregas, Joan, Bernstein, Richard A., Johnston, S. Claiborne
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735409/
https://ncbi.nlm.nih.gov/pubmed/31490536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.10769
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares